{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:58:06Z","timestamp":1790521086789,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1053\/j.seminhematol.2015.01.009","type":"journal-article","created":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T15:37:18Z","timestamp":1421854638000},"page":"97-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["MYC Alterations in Diffuse Large B-Cell Lymphomas"],"prefix":"10.1053","volume":"52","author":[{"given":"Kennosuke","family":"Karube","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2015.01.009_bib1","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/nrc2231","article-title":"Reflecting on 25 years with MYC","volume":"8","author":"Meyer","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib2","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/ni.2428","article-title":"The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry","volume":"13","author":"Dominguez-Sola","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib3","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/ni.2418","article-title":"The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers","volume":"13","author":"Calado","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib4","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1182\/blood-2013-05-498329","article-title":"Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification","volume":"122","author":"Ott","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib5","unstructured":"Swerdlow SH. Diagnosis of \u201cDouble hit\u201d diffuse large B-cell lymphoma and B-cell lymphoma unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC. Hematology. In press."},{"key":"10.1053\/j.seminhematol.2015.01.009_bib6","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1038\/sj.onc.1210376","article-title":"Rituximab therapy in malignant lymphoma","volume":"26","author":"Coiffier","year":"2007","journal-title":"Oncogene"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib7","series-title":"World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues","year":"2009"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1177\/1947601910379012","article-title":"Transcriptional repression: the dark side of myc","volume":"1","author":"Herkert","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib9","doi-asserted-by":"crossref","first-page":"e6693","DOI":"10.1371\/journal.pone.0006693","article-title":"A core MYC gene expression signature is prominent in basal-like breast cancer but only partially overlaps the core serum response","volume":"4","author":"Chandriani","year":"2009","journal-title":"PLoS One"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib10","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1101\/gad.1712408","article-title":"Myc\u05f3s broad reach","volume":"22","author":"Eilers","year":"2008","journal-title":"Genes Dev"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cell.2012.08.033","article-title":"c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells","volume":"151","author":"Nie","year":"2012","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cell.2012.08.026","article-title":"Transcriptional amplification in tumor cells with elevated c-Myc","volume":"151","author":"Lin","year":"2012","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nature13537","article-title":"Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis","volume":"511","author":"Sabo","year":"2014","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nature13473","article-title":"Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles","volume":"511","author":"Walz","year":"2014","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature13518","article-title":"Gene regulation: fine-tuned amplification in cells","volume":"511","author":"Dang","year":"2014","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib16","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.celrep.2013.04.002","article-title":"Cdc45 is a critical effector of myc-dependent DNA replication stress","volume":"3","author":"Srinivasan","year":"2013","journal-title":"Cell Rep"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib17","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00018-011-0860-x","article-title":"Tumor microenvironment: becoming sick of Myc","volume":"69","author":"Whitfield","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib18","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2141.2010.08159.x","article-title":"Advances in the understanding of MYC-induced lymphomagenesis","volume":"149","author":"Klapproth","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib19","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3324\/haematol.2013.086173","article-title":"MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"98","author":"Valera","year":"2013","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib20","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","article-title":"Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/ejh.12212","article-title":"MYC translocation partner gene determines survival of patients with large B-cell lymphoma with MYC- or double-hit MYC\/BCL2 translocations","volume":"92","author":"Pedersen","year":"2014","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib22","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","article-title":"Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab","volume":"28","author":"Barrans","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib23","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood.V77.7.1516.1516","article-title":"Patterns of chromosomal breakpoint locations in Burkitt\u05f3s lymphoma: relevance to geography and Epstein-Barr virus association","volume":"77","author":"Shiramizu","year":"1991","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib24","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1002\/j.1460-2075.1993.tb06069.x","article-title":"Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt\u05f3s lymphoma cells","volume":"12","author":"Polack","year":"1993","journal-title":"EMBO J"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.leu.2404529","article-title":"Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas","volume":"21","author":"Bertrand","year":"2007","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib26","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2012-02-412791","article-title":"IgH partner breakpoint sequences provide evidence that AID initiates t(11;14) and t(8;14) chromosomal breaks in mantle cell and Burkitt lymphomas","volume":"120","author":"Greisman","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib27","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1038\/sj.onc.1204595","article-title":"Translocations involving c-myc and c-myc function","volume":"20","author":"Boxer","year":"2001","journal-title":"Oncogene"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib28","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3324\/haematol.2013.091827","article-title":"Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma","volume":"99","author":"Aukema","year":"2014","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib29","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3324\/haematol.2009.012864","article-title":"Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma","volume":"95","author":"Stasik","year":"2010","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/35085588","article-title":"Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas","volume":"412","author":"Pasqualucci","year":"2001","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib31","first-page":"3383","article-title":"Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas","volume":"54","author":"Clark","year":"1994","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib32","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nature03845","article-title":"Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants","volume":"436","author":"Hemann","year":"2005","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib33","doi-asserted-by":"crossref","first-page":"e33813","DOI":"10.1371\/journal.pone.0033813","article-title":"Immunohistochemical detection of MYC-driven diffuse large B-cell lymphomas","volume":"7","author":"Kluk","year":"2012","journal-title":"PLoS One"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib34","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","article-title":"Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Johnson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib35","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2012-06-435842","article-title":"MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma","volume":"121","author":"Horn","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib36","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/PAS.0b013e318244e2ba","article-title":"High levels of nuclear MYC protein predict the presence of MYC rearrangement in diffuse large B-cell lymphoma","volume":"36","author":"Green","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib37","article-title":"Diffuse large B-cell lymphomas of immunoblastic type are a major reservoir for MYC-IGH translocations","author":"Horn","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib38","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PAS.0b013e31826cebad","article-title":"Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas","volume":"37","author":"Pillai","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib39","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1200\/JCO.2010.32.8385","article-title":"The gray zone between Burkitt\u05f3s lymphoma and diffuse large B-cell lymphoma from a genetics perspective","volume":"29","author":"Salaverria","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1309\/AJCPBWVHTF7RRSA4","article-title":"Aggressive B-cell lymphomas with translocations involving BCL6 and MYC have distinct clinical-pathologic characteristics","volume":"142","author":"Turakhia","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib41","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","article-title":"MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy","volume":"114","author":"Savage","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib42","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/leu.2008.344","article-title":"Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24\/c-MYC translocations","volume":"23","author":"Niitsu","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib43","doi-asserted-by":"crossref","first-page":"e95020","DOI":"10.1371\/journal.pone.0095020","article-title":"C-MYC aberrations as prognostic factors in diffuse large B-cell lymphoma: a meta-analysis of epidemiological studies","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS One"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib44","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/modpathol.2011.147","article-title":"B-cell lymphomas with MYC\/8q24 rearrangements and IGH@BCL2\/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome","volume":"25","author":"Li","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib45","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/PAS.0b013e3181db83af","article-title":"Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation","volume":"34","author":"Ruzinova","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib46","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of Burkitt\u05f3s lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib47","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt\u05f3s lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib49","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ng.2469","article-title":"Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing","volume":"44","author":"Richter","year":"2012","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib50","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood-2013-02-483727","article-title":"Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing","volume":"122","author":"Morin","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib51","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib52","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib53","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.1205299110","article-title":"Genetic heterogeneity of diffuse large B-cell lymphoma","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib54","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3324\/haematol.13071","article-title":"Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt\u05f3s lymphoma","volume":"93","author":"Salaverria","year":"2008","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib55","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3324\/haematol.11305","article-title":"The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24\/c-MYC rearrangement","volume":"92","author":"Le Gouill","year":"2007","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib56","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/PAS.0b013e3181cd3aeb","article-title":"B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma","volume":"34","author":"Snuderl","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib57","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/bjh.12343","article-title":"B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases","volume":"162","author":"Perry","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib58","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/PAS.0000000000000147","article-title":"Clinical significance of MYC expression and\/or \"high-grade\" morphology in non-Burkitt, diffuse aggressive B-cell lymphomas: a SWOG S9704 correlative study","volume":"38","author":"Cook","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib59","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/01.pas.0000168176.71405.e5","article-title":"Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma","volume":"29","author":"Haralambieva","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib60","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1097\/01.pas.0000180442.87022.08","article-title":"Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior","volume":"29","author":"McClure","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib61","first-page":"4771","article-title":"ID3 mutations are recurrent events in double-hit B-cell lymphomas","volume":"33","author":"Gebauer","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib62","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1365-2559.2012.04339.x","article-title":"Plasmablastic lymphoma of the elderly: a clinicopathological comparison with age-related Epstein-Barr virus-associated B cell lymphoproliferative disorder","volume":"61","author":"Liu","year":"2012","journal-title":"Histopathology"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib63","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1309\/AJCPFUR1BK0UODTS","article-title":"Plasmablastic lymphomas with MYC\/IgH rearrangement: report of three cases and review of the literature","volume":"132","author":"Bogusz","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib64","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/PAS.0b013e3181f3e29f","article-title":"IG\/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas","volume":"34","author":"Valera","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib65","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/PAS.0000000000000234","article-title":"Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases","volume":"38","author":"Morscio","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib66","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/modpathol.2010.72","article-title":"Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features","volume":"23","author":"Taddesse-Heath","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib67","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1200\/JCO.2008.21.5020","article-title":"Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis","volume":"27","author":"Laurent","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib68","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.humpath.2011.01.012","article-title":"Anaplastic lymphoma kinase-positive large B-cell lymphoma with complex karyotype and novel ALK gene rearrangements","volume":"42","author":"Shi","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib69","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/modpathol.2013.73","article-title":"ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements","volume":"26","author":"Valera","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib70","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1365-2141.1999.01678.x","article-title":"Molecular features of primary mediastinal B-cell lymphoma: involvement of p16INK4A, p53 and c-myc","volume":"107","author":"Scarpa","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib71","first-page":"2017","article-title":"Molecular characterization of primary mediastinal B cell lymphoma","volume":"148","author":"Tsang","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib72","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ccr.2010.11.013","article-title":"Cooperative epigenetic modulation by cancer amplicon genes","volume":"18","author":"Rui","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib73","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1101\/gad.7.4.671","article-title":"A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice","volume":"7","author":"Davis","year":"1993","journal-title":"Genes Dev"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib74","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib75","article-title":"Inhibition of bromodomain proteins for the treatment of human diffuse large B-cell lymphoma","author":"SE","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib76","doi-asserted-by":"crossref","first-page":"E2721","DOI":"10.1073\/pnas.1406722111","article-title":"BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma","volume":"111","author":"Bhadury","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib77","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1182\/blood-2012-08-446096","article-title":"Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomas","volume":"121","author":"Shortt","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.009_bib78","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.14694\/EdBook_AM.2014.34.e497","article-title":"Taking on challenging targets: making MYC druggable","author":"Horiuchi","year":"2014","journal-title":"Am Soc Clin Oncol Educ Book"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196315000104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196315000104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:24:24Z","timestamp":1758522264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196315000104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0037196315000104"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2015.01.009","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MYC Alterations in Diffuse Large B-Cell Lymphomas","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2015.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}